Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06556238 · ClinicalTrials.gov registry record · NA
Metabolism-Informed Care to Aid Alaska Native People to Quit Smoking (QUIT)
A NA study of Smoking Cessation, sponsored by Southcentral Foundation.
- Recruiting
- Registry status
- NA
- Development phase
- 50
- Enrollment target
- 1
- Study location
NCT06556238 is a NA study of Smoking Cessation that is actively recruiting participants, run by Southcentral Foundation. The registered enrollment target is 50 participants, below the 474-participant average among 188 other Smoking Cessation trials with a reported enrollment target (89% lower). The trial reports 1 study location across 1 state.
The verdict
NCT06556238, a NA study of Smoking Cessation, is actively recruiting participants, sponsored by Southcentral Foundation.
- RECRUITING
- Registry status
- NA
- Development phase
- 50 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to refine and pilot an intervention using the Nicotine Metabolite Ratio (NMR) to inform the selection of pharmacologic treatment to increase smoking abstinence among Alaska Native and American Indian people. This is a single-arm pilot trial to assess and improve acceptability and feasibility.
Conditions Studied
Interventions
- OTHER Nicotine Metabolite Ratio
Study Locations (1)
Alaska
- Anchorage Native Primary Care Center - Anchorage
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2025-11-17 |
| Est. Completion | 2026-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06556238
The ClinicalTrials.gov registry entry for NCT06556238 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 474-participant average among 188 other Smoking Cessation trials with a reported enrollment target (89% lower). The listed sponsor is Southcentral Foundation, which has 4 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Smoking Cessation appearing as the primary indexed condition, and to 1 intervention - of which Nicotine Metabolite Ratio is the first listed.
NCT06556238 reports 1 study location spanning 1 distinct geographic area - top geographies include Alaska.
Frequently Asked Questions
What is clinical trial NCT06556238 about?
NCT06556238 is a clinical study titled "Metabolism-Informed Care to Aid Alaska Native People to Quit Smoking (QUIT)". The purpose of this study is to refine and pilot an intervention using the Nicotine Metabolite Ratio (NMR) to inform the selection of pharmacologic treatment to increase smoking abstinence among Alaska Native and American Indian people. This is a single-arm pilot trial to assess and improve acceptab...
What is the current status of trial NCT06556238?
This trial is currently recruiting. It is a NA study. The enrollment target is 50 participants. The study started on 2025-11-17. Estimated completion is 2026-06.
What conditions does trial NCT06556238 study?
This clinical trial studies the following conditions: Smoking Cessation.
What interventions are being tested in trial NCT06556238?
The interventions under investigation include: Nicotine Metabolite Ratio (OTHER).
Who is sponsoring clinical trial NCT06556238?
This trial is sponsored by Southcentral Foundation, which has 4 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06556238 being conducted?
This trial has 1 study location across Alaska. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Smoking Cessation
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Clinical Research Evaluating Smoking Cessation With E-Cigarettes and Nicotine Therapy
RECRUITING · NA
-
Scalable TELeheaLth Cancer CARe: The STELLAR Program to Treat Cancer Risk Behaviors
RECRUITING · NA
-
ACT Lung Health Intervention: Phase Two
RECRUITING · NA
-
Refer2Quit: Evaluating a Proactive, Tailored, Population Health Approach for Tobacco Treatment for Household Smokers Through a Pediatric Care Network
RECRUITING · NA
-
Baby Steps III: Testing a Clinician and Patient Intervention to Promote Smoking Cessation Among Pregnant Women
RECRUITING · NA
-
Urban and Reservation Implementation of All Nations Breath of Life
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.